Strategic Considerations For A Successful CNS Clinical Development Pathway
Dr. Beatrice Setnik, Chief Scientific Officer at Altasciences, discusses tactics for a successful clinical development pathway for CNS-active drugs.
Specifically, the topics discussed include:
- How to leverage your early phase clinical trials to capture relevant data to characterize your CNS-active drug.
- The methods to determine the need for additional studies and enable developers to accurately project their clinical development timeline and have more informed discussions with regulatory agencies.
VIEW THE WEBINAR! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader X
Subscribe to Clinical Leader